Home › Funds › Sio Capital Management, LLC › ABT

Sio Capital Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Sio Capital Management, LLC reported holding 128,656 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$11.7M, representing 1.93% of its reported portfolio and ranking #18 among its reported holdings. Sio Capital Management, LLC has disclosed ABT holdings in 3 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)128.66K sh
Reported value held$11.67M
Portfolio Weight1.93%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's ABT position evolved

Sio Capital Management, LLC first disclosed a stake in ABT in Q2 2024 at 89,500 shares (US$9.3M). The position peaked in Q1 2026 at 186,574 shares, worth US$19.2M. Across 3 filings, Sio Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 128,656 shares valued at US$11.7M — a reduction of -57,918 shares quarter over quarter.. Notable position changes include a 31% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 89.50K $9.30M New
Q1 2026 186.57K $19.16M New
Q2 2026 128.66K $11.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Sio Capital Management, LLC held ABT?

Sio Capital Management, LLC has disclosed ABT holdings in 3 of the last 9 reported quarters, going back to Q2 2024.

What is Sio Capital Management, LLC's current position in ABT?

As of Q2 2026, Sio Capital Management, LLC holds 128.66K shares of ABT (ABBOTT LABORATORIES), valued at $11.67M, representing 1.93% of its reported portfolio and ranking #18.

Has Sio Capital Management, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), Sio Capital Management, LLC reduced its position in ABT. The position peaked in Q1 2026 at 186.57K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.